Augustine Lawlor is Director at HUMAN GENOME SCIENCES INC (HGSI). They have made 12 open-market trades across 5 companies since 2014, most recently 2025-03-28.
CIK 0001262327
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $16.0M since 2014, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBIO | SELL | 2020-02-25 | 2020-02-25 | $6.10 | $847K | -7.8% | -36.3% | -20.7% |
| LPTX | BUY | 2019-02-05 | 2019-02-05 | $1.75 | $1000K | +6.5% | -4.5% | +8.4% |
| LPTX | BUY | 2017-11-14 | 2017-11-16 | $6.09 | $12.9M | -5.9% | -7.5% | -6.2% |
| GBIM | SELL | 2016-03-18 | 2016-03-18 | $1.55 | $17K | +6.6% | +2.6% | +4.6% |
| GBIM | SELL | 2016-03-15 | 2016-03-17 | $2.05 | $5K | +23.7% | +32.2% | -7.2% |
| GBIM | SELL | 2016-03-10 | 2016-03-14 | $1.60 | $26K | -11.6% | -10.2% | -13.4% |
| GBIM | SELL | 2016-03-04 | 2016-03-08 | $1.05 | $16K | +57.0% | +103.5% | +11.4% |
| GBIM | SELL | 2016-03-01 | 2016-03-03 | $1.11 | $18K | +109.5% | +117.1% | +23.0% |
| GBIM | SELL | 2016-02-25 | 2016-02-29 | $0.98 | $15K | +11.8% | +84.3% | +16.7% |
| GBIM | SELL | 2016-02-22 | 2016-02-24 | $1.33 | $20K | -8.1% | +51.2% | -5.7% |
| CSII | SELL | 2014-08-21 | 2014-08-25 | $28.05 | $10.1M | -10.8% | -2.0% | -2.0% |
| TRVN | BUY | 2014-02-05 | 2014-02-07 | $7.00 | $2.1M | -25.2% | -5.0% | -5.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.